Evidence map›Paper›PMID 31971829›Full record

ArticleThe British journal of radiology2020

Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.

Lynsey Devlin, David Dodds, Azmat Sadozye, Philip McLoone, Nicholas MacLeod, Carolynn Lamb, Suzanne Currie, Stefanie Thomson, Aileen Duffton

Open access · greenAbstract read
In one paragraph

Article in The British journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lynsey DevlinDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0002-4047-0686
David DoddsDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Azmat SadozyeDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Philip McLooneInstitute of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Nicholas MacLeodDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Carolynn LambDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Suzanne CurrieDepartment of Clinical Physics and Bioengineering, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Stefanie ThomsonDepartment of Clinical Physics and Bioengineering, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Aileen DufftonDepartment of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Beatson West of Scotland Cancer Centre · GBUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveProstate stereotactic ablative radiotherapy (SABR) delivers large doses using a fast dose rate. This amplifies the effect geometric uncertainties have on normal tissue dose. The aim of this study was to determine whether the treatment dose-volume histogram (DVH) agrees with the planned dose to organs at risk (OAR).

methods41 low-intermediate risk prostate cancer patients were treated with SABR using a linac based technique. Dose prescribed was 35 Gy in five fractions delivered on alternate days, planned using volumetric modulated arc therapy (VMAT) with 10X flattening filter free (FFF). On treatment, prostate was matched to fiducial markers on cone beam CT (CBCT). OAR were retrospectively delineated on 205 pre-treatment CBCT images. Daily CBCT contours were overlaid on the planning CT for dosimetric analysis. Verification plan used to evaluate the daily DVH for each structure. The daily doses received by OAR were recorded using the D%.

resultsThe median rectum and bladder volumes at planning were 67.1 cm

conclusionIn this cohort of prostate SABR patients, we estimate the OAR treatment DVH was higher than planned. This was due to rectal and bladder organ variation. ADVANCES IN KNOWLEDGE: OAR variation in prostate SABR using a FFF technique, may cause the treatment DVH to be higher than planned.

Indexed as

AgedDose Fractionation, RadiationHumansMaleOrgans at RiskProstateProstatic NeoplasmsRadiometryRadiosurgeryRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRectumRetrospective StudiesUrinary Bladder

Identifiers

PMID31971829
PMCPMC7362910
OpenAlexW3002549863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.